PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease

Brain Pathology

Volumn 20, Issue 2, 2010, Pages 419-430

  Kepe, Vladimir ^a   Ghetti, Bernardino ^b   Farlow, Martin R ^b   Bresjanac, Mara ^c   Miller, Karen ^a   Huang, Sung Cheng ^a   Wong, Koon Pong ^a   Murrell, Jill R ^b   Piccardo, Pedro ^b   Epperson, Francine ^b   Repovš, Grega ^c   Smid, Lojze M ^a,c   Petrič, Andrej ^c   Siddarth, Prabha ^a   Liu, Jie ^a   Satyamurthy, Nagichettiar ^a   Small, Gary W ^a   Barrio, Jorge R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

F 18 FDDNP; F 18 FDG; Amyloid; Familial prion disease; GSS A117V; GSS F198S "Indiana kindred"; GSS P102L; Positron emission tomography; PRNP gene mutation; Tau; Transmissible spongiform encephalopathy

Indexed keywords

2 [1 [6 [(2 FLUOROETHYL)(METHYL)AMINO] 2 NAPHTHYL]ETHYLIDENE]MALONONITRILE F 18; AMYLOID PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PRION PROTEIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN DYSFUNCTION; BRAIN LEVEL; BRAIN TISSUE; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GERSTMANN STRUSSLER SCHEINKER DISEASE; GLUCOSE METABOLISM; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERVENTION STUDY; MALE; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; PRION PROTEIN GENE; THALAMUS;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; NITRILES; POSITRON-EMISSION TOMOGRAPHY; PRIONS; TAU PROTEINS;

EID: 75949105175     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00306.x     Document Type: Article

References (37)

1. Boxer A, Rabinovici G, Kepe V, Goldman J, Furst AJ, Huang S-C et al (2007) Amyloid imaging in distinguishing prion disease from Alzheimer disease. Neurology 69 : 283 290. (Pubitemid 47205691)
2. Bresjanac M, Smid LM, Vovko TD, Petrič A, Barrio JR, Popovic M (2003) Molecular imaging probe 2-(1-{6-[(2-fluoroethyl)(methyl)amino]-2- naphthyl}ethylidene)-malononitrile labels prion plaques in vitro. J Neurosci 23 : 8029 8033.
3. Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24 : 519 550.
4. Collinge J (2005) Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 76 : 906 919.
5. DeArmond SJ, Prusiner SB (1995) Etiology and pathogenesis of prion disease. Am J Pathol 146 : 785 811.
6. DeArmond SJ, Prusiner SB (2003) Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin Lab Med 23 : 1 41.
7. Farlow MR, Yee RD, Dlouhy SR, Conneally PM, Azzarelli B, Ghetti B (1989) Gerstmann-Sträussler-Scheinker disease: I. Extending the clinical spectrum. Neurology 39 : 1446 1452.
8. Gambetti P, Parchi P, Chen SG (2003) Herediatry Creutzfeldt-Jakob disease and fatal familial insomnia. Clin Lab Med 23 : 43 64.
9. Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L et al (1989) Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39 : 1453 1461.
10. Ghetti B, Tagliavini F, Takao M, Bugiani O, Piccardo P (2003) Hereditary prion protein amyloidosis. Clin Lab Med 23 : 65 85.
11. Goldfarb LV, Brown P (1995) The transmissible spongiform encephalopathies. Annu Rev Med 47 : 57 65.
12. 18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 249 : 699 705.
13. Hsiao KK, Cass C, Schellenberg GD, Bird T, Devine-Gage E, Wisniewski H et al (1991) A prion protein variant in a family with the telencephalic form of Gerstmann-Sträussler-Scheinker syndrome. Neurology 41 : 681 684.
14. Irisawa M, Amanuma M, Kozawa E, Kimura F, Araki N (2007) A case of Gerstmann-Sträussler-Scheinker syndrome. Magn Reson Med Sci 6 : 53 57.
15. Ishikawa K, Doh-ura K, Kudo Y, Nishida N, Murakami-Kubo I, Ando Y et al (2004) Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies. J Gen Virol 85 : 1785 1790.
16. Kepe V, Barrio JR, Huang S-C, Ercoli L, Siddarth P, Shoghi-Jadid K et al (2006) Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci USA 103 : 702 707. (Pubitemid 43153089)
17. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK et al (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27 : 6174 6184.
18. Lezak MD, Howieson D, Loring D (2004) Neuropsychological Assessment, 4th edn. Oxford University Press : New York.
19. 18F]FDDNP) ready for animal and human administration. Mol Imaging Biol 9 : 6 16.
20. Logan J, Fowler J, Volkow N, Wang G, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metabol 16 : 834 840.
21. Mastrianni JA, Roos RP (2000) The prion diseases. Semin Neurol 20 : 337 352.
22. Mazziotta JC, Phelps ME, Pahl JJ, Huang SC, Baxter LR, Riege WH et al (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 316 : 357 362.
23. Molnár MJ, Valikovics A, Molnár S, Trón L, Diószeghy P, Mechler F et al (2000) Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 55 : 544 548.
24. Padgett HC, Schmidt DG, Luxen A, Bida GT, Satyamurthy N, Barrio JR (1989) Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. Int J Rad Appl Instrum A 40 : 433 445.
25. Parchi P, Gambetti P (1998) Human prion diseases. Curr Opin Neurol 8 : 286 295.
26. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95 : 13363 13383.
27. Prusiner SB (2001) Shattuck lecture - neurodegenerative diseases and prions. N Engl J Med 344 : 1516 1526.
28. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE (1998) Prion protein biology. Cell 93 : 337 348.
29. Sadowski M, Pankiewicz J, Scholtzova H, Tsai J, Li Y, Carp RI et al (2004) Targeting prion amyloid deposits in vivo. J Neuropathol Exp Neurol 63 : 775 784.
30. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268 : 20276 20284.
31. Small GW, Kepe V, Ercoli L, Siddarth P, Bookeheimer SY, Miller KJ et al (2006) PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355 : 2652 2663.
32. Smid LM, Vovko TD, Popovic M, Petrič A, Kepe V, Barrio JR et al (2006) The 2,6-disubstituted naphthalene derivative FDDNP labeling reliably predicts Congo red birefringence of protein deposits in brain sections of selected human neurodegenerative diseases. Brain Pathol 16 : 124 130.
33. Taber KH, Cortelli P, Staffen W, Harley R (2002) The expanding role of imaging in prion disease. J Neuropsychiatry Clin Neurosci 14 : 371 376.
34. Tanaka Y, Minematsu K, Moriyasu H, Yamaguchi T, Takenori Y, Kitamoto T et al (1997) A Japanese family with a variant of Gerstmann-Sträussler- Scheinker disease. J Neurol Neurosurg Psychiatry 62 : 454 457.
35. Uchino A, Yoshinaga M, Shiokawa O, Hata H, Ohno M (1991) Serial MR imaging in Creutzfeldt-Jakob disease. Neuroradiology 33 : 364 367.
36. Webb TE, Poulter M, Beck J, Uphill J, Adamson G, Campbell T et al (2008) Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 131 : 2632 2646.
37. 18F]FDDNP PET data. In: Conference Record, 2007 IEEE Nuclear Science Symposium and Medical Imaging Conference, Honolulu, Hawaii, 2007, pp. 3146 3150.